Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial

BACKGROUND: Our aim was to establish if presence of circulating tumor cells (CTCs) predicted worse outcome in patients with non-metastatic esophageal cancer undergoing tri-modality therapy. METHODS: We prospectively collected CTC data from patients with operable non-metastatic esophageal cancer from...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Edward, Allan, Alison L., Sanatani, Michael, Lewis, Debra, Warner, Andrew, Dar, A. Rashid, Yaremko, Brian P., Lowes, Lori E., Palma, David A., Raphael, Jacques, Vincent, Mark D., Rodrigues, George B., Fortin, Dalilah, Inculet, Richard I., Frechette, Eric, Bierer, Joel, Law, Jeffery, Younus, Jawaid, Malthaner, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264673/
https://www.ncbi.nlm.nih.gov/pubmed/35804307
http://dx.doi.org/10.1186/s12885-022-09846-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264673/
https://www.ncbi.nlm.nih.gov/pubmed/35804307
http://dx.doi.org/10.1186/s12885-022-09846-0

Ejemplares similares